Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blair K A Willette

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|January 25, 2024
Functional diversification of cell signaling by GPCR localizationMatthew J Klauer, Blair K A Willette, Nikoleta G Tsvetanova
Nature Chemical Biology|July 27, 2023
Endosome positioning coordinates spatially selective GPCR signalingBlair K A Willette, Jin-Fan Zhang, Jin Zhang, et al.
Pharmacology, Biochemistry, and Behavior|August 31, 2019
Acute and chronic interactive treatments of serotonin 5HT<sub>2C</sub> and dopamine D<sub>1</sub> receptor systems for decreasing nicotine self-administration in female ratsBlair K A Willette, Anica Nangia, Sarah Howard, et al.
Science Signaling|February 6, 2020
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivityMarta Sanchez-Soto, Ravi Kumar Verma, Blair K A Willette, et al.
Biomolecules|October 28, 2023
G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D<sub>2</sub> Dopamine Receptor through Mechanisms That Are Independent of Receptor PhosphorylationMarta Sánchez-Soto, Noelia M Boldizsar, Kayla A Schardien, et al.
Molecular Pharmacology|August 6, 2021
Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D<sub>2</sub> Dopamine ReceptorR Benjamin Free, Caroline A Cuoco, Bing Xie, et al.
Molecular Pharmacology|August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding SitesKathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|January 25, 2024
Functional diversification of cell signaling by GPCR localizationMatthew J Klauer, Blair K A Willette, Nikoleta G Tsvetanova
Nature Chemical Biology|July 27, 2023
Endosome positioning coordinates spatially selective GPCR signalingBlair K A Willette, Jin-Fan Zhang, Jin Zhang, et al.
Pharmacology, Biochemistry, and Behavior|August 31, 2019
Acute and chronic interactive treatments of serotonin 5HT<sub>2C</sub> and dopamine D<sub>1</sub> receptor systems for decreasing nicotine self-administration in female ratsBlair K A Willette, Anica Nangia, Sarah Howard, et al.
Science Signaling|February 6, 2020
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivityMarta Sanchez-Soto, Ravi Kumar Verma, Blair K A Willette, et al.
Biomolecules|October 28, 2023
G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D<sub>2</sub> Dopamine Receptor through Mechanisms That Are Independent of Receptor PhosphorylationMarta Sánchez-Soto, Noelia M Boldizsar, Kayla A Schardien, et al.
Molecular Pharmacology|August 6, 2021
Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D<sub>2</sub> Dopamine ReceptorR Benjamin Free, Caroline A Cuoco, Bing Xie, et al.
Molecular Pharmacology|August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding SitesKathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Pageof 1